SeaStar Medical Holding (ICU) Other financing activities (2021 - 2025)
SeaStar Medical Holding's (ICU) quarterly Other financing activities came in at $5.9 million in Q3 2025, up 101.99% YoY from $2.9 million in Q3 2024, and up 223.02% on a QoQ basis from -$4.8 million in Q2 2025.
SeaStar Medical Holding (ICU) Other financing activities (2021 - 2025) Analysis & Trends
SeaStar Medical Holding (ICU) has 4 years of Other financing activities data on file, last reported at $5.9 million in Q3 2025.
- Quarterly Other financing activities rose 101.99% year-over-year to $5.9 million in Q3 2025, while the trailing twelve-month figure through Mar 2026 was $1.1 million (down 85.7% YoY) and the FY2025 annual result came in at $5.9 million, up 56.29% from the prior year.
- Other financing activities advanced to $5.9 million in Q3 2025, from -$4.8 million in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $5.9 million in Q3 2025 to a low of -$4.8 million in Q2 2025.
- A 4-year average of $2.3 million and a median of $2.9 million in 2024 frame the typical range for Other financing activities.
- The widest YoY moves for Other financing activities: up 460.96% in 2025, down 101.99% in 2025.
- Tracing ICU's Other financing activities over 4 years: stood at $5.7 million in 2021, then tumbled by 89.68% to $592000.0 in 2023, then surged by 392.06% to $2.9 million in 2024, then surged by 101.99% to $5.9 million in 2025.
- The last three Other financing activities figures came in at $5.9 million (Q3 2025), -$4.8 million (Q2 2025), and $4.8 million (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.83 Bn | 130.98 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.79 Bn | 77.79 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.95 Bn | 59.77 Bn | 1.37 Bn |
| 4 | Moderna | 58.59 Bn | 53.46 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.93 Bn | 36.83 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.52 Bn | 28.21 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.98 Bn | 9.58 Bn | 668.28 Mn |
| 8 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - |
| 10 | SeaStar Medical Holding | 13.91 Mn | 6.91 Mn | 561,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 5.88 Mn |
| Sep 30, 2025 | 5.88 Mn |
| Jun 30, 2025 | -4.78 Mn |
| Jun 30, 2025 | -4.78 Mn |
| Mar 31, 2025 | 4.79 Mn |
| Mar 31, 2025 | 4.79 Mn |
| Sep 30, 2024 | 2.91 Mn |
| Sep 30, 2024 | 2.91 Mn |
| Mar 31, 2024 | 853,000.00 |
| Mar 31, 2024 | 853,000.00 |
| Dec 31, 2023 | 592,000.00 |
| Dec 31, 2023 | 592,000.00 |
| Mar 31, 2021 | 5.74 Mn |
| Mar 31, 2021 | 5.74 Mn |